The Effects of Deferoxamine on the Up regulation of Chemokine Receptor 2 in Bone Marrow Stromal Stem Cells
Journal of Otorhinolaryngology and Facial Plastic Surgery,
Vol. 3 No. 1 (2017),
16 August 2017
https://doi.org/10.22037/orlfps.v3i1.18647
Abstract
Background: Bone marrow stromal stem cells (BMSCs) are non-hematopoietic, stromal cellsthat can differentiate into mesenchymal and other type of tissues. The BMSCs have properties that make them ideal candidates for tissue engineering. The present study aimed to investigate the effect of deferoxamine (DFO) on homing of bone marrow-derived mesenchymal stem cell, and to examine if DFO can increase migration and subsequent homing of mesenchymal stem cells (MSCs) in vitro.
Methods: BMSCs were isolated from the long bones of NMARI rats through density gradientcentrifugation and adherent cell culture. Next, they were treated using DFO in Dulbecco’s modified eagle medium (DMEM) for 24 h. The expression of chemokine receptor 2 (CCR2) were assessed using RT-PCR.
Results: BMSCs expressed CCR2 on a large proportion of cells. In DFO-treated BMSCs,expression of CCR2 (P<0.005) significantly increased compared to that in control groups. Elevation and up regulation of CCR2 in DFO-treated MSCs were observed.
Conclusion: Preconditioning of BMSCs using DFO prior to transplantation could increasehoming of BMSCs through affecting some chemokine receptors as well as proteases involved and thus improve the efficacy of cell therapy.- BMSCs Chemokine Receptor 2 Deferoxamine
How to Cite
References
Abbaszadeh HA, Tiraihi T, Noori-Zadeh A, Delshad AR, Sadeghizade M, Taheri T. Human ciliaryneurotrophic factor–over-expressing stable bone marrow stromal cells in the treatment of a rat model of traumatic spinal cord injury. Cytotherapy. 2015; 17(7):912-21.
Abbaszadeh HA, Tiraihi T, Delshad A, Saghedizadeh M, Taheri T, Kazemi H. Differentiation of Neurosphere-derived rat neural stem cells into Oligodendrocyte-like cells by repressing PDGF-α and Olig2 with triiodothyronine. Tissue and Cell. 2014; 46(6):462-69.
MH Karimfar, AAPeyvandi, M Noorozian, N AhmadiRoozbahani, R Mastery Farahani,MSKhoramgah, A BahadoriMonfared, HA Abbaszadeh. Repressing of SOX6 and SOX9 in Situ Chondrogenic Differentiation of Rat Bone Marrow Stromal Cells.Anatomical Sciences Journal 2015; 12 (2), 75-82
Prockop DJ. Marrow stromal cells as stem cells for nonhemat-opoietic tissues. Science. 1997; 276(5309):71–74.
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284(5411):143–47. doi: 10.1126/sci-ence.284.5411.143
Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacy-tidine. Muscle & Nerve. 1995; 18(12):1417–426. doi: 10.1002/ mus.880181212
HA Abbaszadeh, T Tiraihi, AR Delshad, MS Zadeh, T TaheriBone marrow stromal cell transdifferentiation into oligodendrocyte-like cells using triiodothyronine as a inducer with expression of platelet-derived growth factor α as a maturity marker.2013Iranian biomedical journal 17 (2), 62.
Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al. Human bone marrow stromal cells suppressT-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002; 99(10):3838–843. doi: 10.1182/ blood.v99.10.3838
Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O. HLA expression and immunologic properties of differenti-ated and undifferentiated mesenchymal stem cells. Experi-mental Hematology. 2003; 31(10):890–96. doi: 10.1016/s0301-472x(03)00110-3
Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation ca-pacity, immunological features, and potential for homing. Stem Cells. 2007; 25(11):2739–749. doi: 10.1634/stemcells.2007-0197
Fox J, Chamberlain G, Ashton B, Middleton J. Recent advances into the understanding of mesenchymal stem cell trafficking.British Journal of Haematology. 2007; 137(6):491–502.
Mahmood A, Lu D, Wang L, Li Y, Lu M, Chopp M. Treatment of traumatic brain injury in female rats with intravenous ad-ministration of bone marrow stromal cells. Neurosurgery. 2001; 49(5):1196–203.
Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M. Therapeutic ben-efit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 2001; 32(4):1005–011.
Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasi-bility, cell migration, and body distribution. Circulation. 2003; 108(7):863–68.
Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kamin-ski N, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proceedings of the National Academy of Sci-ences. 2003; 100(4):8407–411.
Campbell JJ, Butcher EC. Chemokines in tissue-specific and mi-croenvironment-specific lymphocyte homing. Current Opin-ion in Immunology. 2000; 12(3):336–41.
Levesque JP, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. Journal of Clinical Investigation. 2003; 111(2):187–96.
Middleton J, Neil S, Wintle J, Clark-Lewis I, Moore H. Trans-cytosis and surface presentation of IL-8 by venular endothelial cells. Cell. 1997; 91(3):385–95.
Butcher EC, Williams M, Youngman K, Rott L, Briskin M. Lym-phocyte trafficking and regional immunity. Advances in Im-munology. 1999; 72:209–53.
Abbaszadeh H-A, Tiraihi T, Sadeghizade M, DelshadA,Taheri T, et al. Improvement of Spinal Cord Injury in Rat Model via Transplantation of Neural Stem Cells Derived From Bone Marrow.Journal of Kerman University of Medical Sciences.2016; 23 (4), 421-435
Von Lüttichau I, Notohamiprodjo M, Wechselberger A, Peters C, Henger A, SeligerCh, et al. Human adult CD34- progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4. Stem Cells and De-velopment. 2005; 14(3):329–36.
Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells. 2006; 24(4):1030–1041. doi: 10.1634/stemcells.2005-0319
Ringe J, Strassburg S, Neumann K, Endres M, Notter M, Burm-ester GR. Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2. Journal of Cellular Biochemistry. 2007; 101(1):135–146.
Hung SC, Pochampally R, Hsu S, Sanchez C, Chen SC, Spees J, et al. Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS ONE. 2007; 2(5):e416.
Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Ex-perimental Biology and Medicine. 2001; 226(6):507–20. PMID: 11395921
Krampera M, Pizzolo G, Aprili G, Franchini M. Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone. 2006; 39(4):678–683. doi: 10.1016/j.bone.2006.04.020
Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood. 2003; 102(10):3837– 844. doi: 10.1182/blood-2003-04-1193
Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. New England Journal of
Medicine. 2006; 354(6):610–21. doi: 10.1056/nejmra052723
Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, et al. Preferential recruitment of CCR6-expressingTh17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. Journal of Experimental Medicine. 2007; 204(12):2803–812.
Mohan K, Issekutz TB. Blockade of chemokine receptor CXCR3 inhibits T cell recruitment to inflamed joints and decreases the severity of adjuvant arthritis. Journal of Immunology. 2007;179(12):8463–469.
Nanki T, Shimaoka T, Hayashida K, Taniguchi K, Yonehara S, Miyasaka N. Pathogenic role of the CXCL16-CXCR6 path-way in rheumatoid arthritis. Arthritis & Rheumatism. 2005; 52(10):3004–014.
Saruta M, Yu QT, Avanesyan A, Fleshner PR, Targan SR, Pa-padakis KA. Phenotype and effector function of CC chemokine receptor 9-expressing lymphocytes in small intestinal Crohn's disease. Journal of Immunology. 2007; 178(5):3293–300.
Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, et al. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood. 2004; 103(5):1662–668.
- Abstract Viewed: 655 times
- PDF Downloaded: 274 times